期刊文献+

(S)-α-乙基-2-氧代-1-吡咯烷基乙酰胺的合成工艺进展 被引量:2

Advances in Preparation of (S)-α- Ehtyl-2-oxo-1-pyrrolidinylacetamide
原文传递
导出
摘要 (S) α 乙基 2 氧代 1 吡咯烷基乙酰胺是制造抗癫痫新药左乙拉西坦的原料药 ,它具有治疗局限性和原发全身性癫痫、预防癫痫发作的独特药理作用 ,且不影响其他抗癫痫药物在体内代谢 ,疗效高 ,耐受性好。评价了 (S) α 乙基 2 氧代 1 吡咯烷基乙酰胺的 6条合成工艺 ,认为以具有正确立体结构的 (S) 2 氨基 4 (甲硫基 )丁酸甲酯盐酸盐为起始原料 ,是合成 (S) α 乙基 2 氧代 1 吡咯烷基乙酰胺的较佳工艺。 S ) α Ehtyl 2 oxo 1 pyrrolidinylacetamide is used as a raw material for manufacturing a new therapeutic agent (Levetiracetam) featuring special pharmacology efficiency for treatment or prevention of epilepsy and other neurological disorders, it has high curative effect, good endurance and without any action on metabolism in vivo of other anti epileptic medicines. The processes totally 6 routes for preparation of (S ) α ehtyl 2 oxo 1 pyrrolidinylacetamide are reviewed. An improved process by using methyl (S ) 2 amino 4 (methylthio)butyrate hydrochloride having normal stereo structure as starting material is recommended.
出处 《精细与专用化学品》 CAS 2004年第24期15-17,共3页 Fine and Specialty Chemicals
基金 北京市优秀人才专项经费资助项目 (2 0 0 3D)
关键词 乙酰胺 癫痫发作 治疗 全身性 原发 抗癫痫药物 新药 乙基 合成工艺 烷基 (S)-α-ehtyl-2-oxo-1-pyrrolidinylacetamide new antiepileptic agent methyl (S)-2-amino-4-(methylthio)butyrate hydrochloride
  • 相关文献

参考文献16

  • 1[1]Wolfgang L, Angelika R . Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activityin a hamster model of paroxysmaldystonia [ J ]. Eur J Pharmacol, 2000,391 (3) :251 ~ 254
  • 2[2]Genton P, Van Vleymen B. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles[J]. Epilepsic Disord, 2000, 2(2):99 ~ 105
  • 3[3]Shorvon S. Pyrrolidine derivatives[J]. Lancet, 2001 , 12: 1885 ~1892
  • 4[4]Kossoff EH, Bergey GK, Freeman JM, Vining EP. Levetiracetam psychosis in children with epilepsy[J]. Epilepsy, 2001, 42 (12):1611 ~ 1613
  • 5[5]Pellock J M, Glauser T A, Bebin E M, et al. Pharmacokinetic study of levetiracetam in children[ J]. Epilepsia,2001,42 ( 12 ): 1574 ~1579
  • 6[6]Kossoff E H, Bergey G K, Freeman J M. Levetiracetam psychosis in children with epilepsy [J]. Epilepsia, 2001, 42 ( 12 ): 1611 ~ 1613
  • 7[7]Pellock J M, Glauser T A, Bebin E M. Pharmacokinetic study of levetiracetam in children[J]. Epilepsia, 2001,42(12) :1574 ~ 1579
  • 8[8]Dooley M, Plosker GL. Levetiracetam: a review of its adjunctive use in the management of partial onset seizures [J]. Drugs, 2000,60(4) :871 ~893
  • 9[9]Harden C. Safety profile of levetiracetam[J]. Epilepsia, 2001, 42(4) :36 ~39
  • 10[10]Ben-Menachem E. Levetiracetam: treatment in epilepsy. Expert Opin Pharmacother[J]. 2003,4 ( 11 ) :2079 ~ 88

同被引文献28

  • 1田国红,赵忠新.左乙拉西坦——一种具有全新作用机制的抗癫痫新药[J].中国新药与临床杂志,2006,25(10):782-786. 被引量:43
  • 2王能强,吴坚平,邹小明,王普,杨立荣.α-氯丙酸脱卤酶发酵培养基的响应面法优化[J].化工学报,2007,58(1):176-180. 被引量:7
  • 3Nina I, Michael R, Stefan S, et al. Enantioselective analysis of levetiracetam and its enantionmer R - α - ethyl - 2 - 0 - 1 - pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection. J Chromatogr B ,2000 ,745 :325.
  • 4Tony W, Chih - chuan C,Ta - Cheng C, et al. Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy : An open - label mutticenter study. Epil Beha ,2009,16:468.
  • 5Francesca B, Pelayo C, Mauro C F, et al. A synthesis of levetiracetam based on (S) - N - phenylpantolaetam as a chiral auxiliary. Tetra : Asym , 2005,16 : 3739.
  • 6Barry E G, Eugene B, Christian O, et al. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepiletic drugs : A pooled analysis of data from randomized clinical trials. Epil Rese,2005,64:1.
  • 7Eric S, Philippe J, Mafia L S M, et al. Modeling and simulation of intravenous levetiracctam pharulacokinetic profiles in children to evaluate dose adaptation rules. Epil Rese, 2007,76 : 140.
  • 8Mukta D,Greg L P. Levetircetam:A review of its adjunctive use in the management of partial onset weizures. Drugs ,2000,60:871.
  • 9Petra M C C, Willem F M A, Robert T H, et al. Add - on levetiracetam in children and adolescents with refractory epilepsy: Results of an open - label multi - centre study. Offi J Euro Paedi Neur Soci, 2008,12:321.
  • 10Tiedong G, Lisa M O, Damodara R M,et al. Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography - electrospray tandem mass spectrometry. Clin Chim Acia,2007,375: 115.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部